The effects of magnesium supplementation on abnormal uterine bleeding, alopecia, quality of life, and acne in women with polycystic ovary syndrome: a randomized clinical trial
Jaripur M, Ghasemi-Tehrani H, Askari G, Gholizadeh-Moghaddam M, Clark CCT, Rouhani MH
Reproductive biology and endocrinology : RB&E · 12 citas
Etiquetas de revisión
Financiación no declaradaDatos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.
Cómo se estudió
- Diseño
- Ensayo controlado aleatorizado (indexado por PubMed)
- Estudiado en
- Personas
- Resultado principal
- Marcadores de salud y funcionamiento
Quién lo pagó
- Financiación
- Financiación no declarada
Publicación
- Publicado
- 2022-08-02 · Reprod Biol Endocrinol · vol. 20 · número 1 · pág. 110
- Editorial
- BioMed Central
- Citado
- 18 citas · más que el 79% de estudios similares · 1.4× el promedio de su campo
- Referencias
- 61 trabajos
- Acceso
- Acceso abierto (revista) · CC-BY
- Áreas de investigación
- Magnesium in Health and Disease · Ovarian function and disorders · Preterm Birth and Chorioamnionitis
- Palabras clave
- Polycystic ovary, Medicine, Acne, Randomized controlled trial, Quality of life (healthcare), Placebo, Internal medicine, Clinical trial, Gynecology, Dermatology, Pathology, Obesity, Alternative medicine, Insulin resistance
- MeSH
- humans, polycystic ovary syndrome, uterine hemorrhage, acne vulgaris, alopecia, magnesium, pregnancy, quality of life, dietary supplements, female, biomarkers
6 autores
- Mahsima Jaripur🇮🇷Isfahan University of Medical Sciences
- Hatav Ghasemi Tehrani🇮🇷Isfahan University of Medical Sciences
- Gholamreza Askari🇮🇷Isfahan University of Medical Sciences
- Mahsa Gholizadeh‐Moghaddam🇮🇷Isfahan University of Medical Sciences
- Cain C. T. Clark🇬🇧Coventry University
- Mohammad Hossein Rouhani🇮🇷Isfahan University of Medical Sciences
Resumen
El texto original del estudio, en el idioma en que se publicó.
Background
Abnormal uterine bleeding (AUB), alopecia, low quality of life, and acne are considered as complications of polycystic ovary syndrome (PCOS). We hypothesized that magnesium supplementation would yield beneficial effects on PCOS related complications.
Objective
To examine the effects of magnesium supplementation on AUB, alopecia, quality of life, and acne.
Methods
In this parallel randomized clinical trial, we randomly assigned 64 women with PCOS to the magnesium group (n = 32) or placebo group (n = 32) for 10 weeks. AUB, alopecia, quality of life, and acne were assessed by the International Federation of Gynecology and Obstetrics criterion, the Sinclair Scale, the Health Survey Quality of Life Questionnaire, and the Global Acne Grading System, respectively. This randomized clinical trial was registered at IRCT.ir (IRCT20130903014551N9).
Results
Magnesium supplementation significantly improved the components of quality of life including physical functioning (p = 0.011), role limitations due to physical health (p = 0.012), role limitations due to emotional problems (p < 0.001), energy/fatigue (p = 0.005), emotional wellbeing (p < 0.001), social functioning (p = 0.002), general health (p = 0.013), and total quality of life (p < 0.001), compared with placebo. No significant effect was observed on acne, alopecia, and AUB.
Conclusion
Magnesium supplementation in women with PCOS had a significant positive effect on improving total quality of life.
Trial registration
This randomized clinical trial was registered at IRCT.ir on 2020-10-18 (Registration Code: IRCT20130903014551N9 ).
Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial (CC BY).
Confianza de la comunidad
Cargando…
¿Cuánto confías en los hallazgos de este estudio?
Comentarios
¿Algo está mal aquí?
Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.
Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.